Global Cardiac Marker Analyzer Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Cardiac Marker Analyzer Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Cardiac Markers Analyzers are medical devices that provide high point-of-care testing solutions used to diagnosis of heart diseases. These devices measure the levels of enzymes and proteins released from the heart in cardiac conditions like myocardial infarction, atrial fibrillation, and others. In addition, these monitors all the cardiac tests such as myoglobin, creatine kinase-muscle/brain (CK-MB), D-dimer and cardiac troponin, through immunochromatographic assays and thus are also known as cardiac reader systems.

Market Overview:

The latest research study on the global Cardiac Marker Analyzer market finds that the global Cardiac Marker Analyzer market reached a value of USD 834.89 million in 2022. It’s expected that the market will achieve USD 1170.95 million by 2028, exhibiting a CAGR of 5.8% during the forecast period.

Negative impact in the short term

The sudden onset of the COVID-19 pandemic, which has led to strict lockdown regulations in many countries, has disrupted the import and export of cardiac marker analyzers. COVID-19 can affect the global economy in three main ways: directly affecting production and demand, causing supply chain and market disruptions, and financially affecting companies and financial markets. The outbreak of the COVID-19 pandemic has severely impacted the cardiac marker analyzer industry. Disruptions to raw material supply chains due to national lockdowns have put pressure on industry product supply. Cardiac marker analyzer products have a demand for diversified distribution channels. The convenience of distribution channels requires distributors with smooth logistics and flexibility. However, the pandemic has hit logistics hard, severely impacting the speed of turnaround. Factors such as labor shortages and increased raw material costs will increase production costs and risks. At the same time, under the impact of the capital market, investor confidence has been frustrated, and corporate financing has become more difficult. Market closures and supply chain disruptions have contributed to weak industrial output growth amid the COVID-19 outbreak. The COVID-19 pandemic has negatively impacted the global economy and has had a significant impact on the cardiac marker analyzer market. Many cardiovascular surgeries have been delayed due to the strict lockdown, and doctors have turned to telemedicine. In addition to this, global availability and sales of cardiac marker analyzers have declined due to stay-at-home policies and disruptions to supply chain activities.

Political Factors

Government Policy Emphasis on Cardiac Disease
Governments of various countries attach great importance to the health of the whole people. Cardiovascular disease, or CV, is one of the important causes of death in the world, and some governments take the prevention and treatment of cardiovascular disease as a national strategic policy. The American Heart Association advocates for robust funding for CDC's Heart Disease and Stroke Prevention Programs, including heart disease and stroke prevention, Million Hearts 2022, and WISEWOMAN. Million Hearts® 2022 is a national initiative co-led by CDC and the Centers for Medicare & Medicaid Services to prevent 1 million heart attacks and strokes in 5 years. The NHS Long Term Plan (NHSLTP) includes a major ambition to prevent 150,000 strokes, heart attacks and dementia cases over the next 10 years. With the global government's attention to the health of the whole people, as well as the attention and popularization of cardiac diseases, this will drive people's attention to cardiac diseases and stimulate the demand for the detection and analysis of cardiac diseases.

Economic Factors

Personal disposable income increases
When disposable income increases, households have more money to save or spend, which naturally leads to increased consumption. In April 2022, U.S. personal disposable income increased by 0.3% month-on-month. In 2021, the median per capita disposable income of Chinese residents will be 29,975 yuan, an increase of 8.8%. With the development of the global economy and the increase in personal disposable, the demand for medical care increases, which drives the increase in the demand for cardiac marker analyzers

Region Overview:

North America dominated the Cardiac Marker Analyzer market in 2022, with a market share of 39.24%.

Company Overview

Abbott Laboratories is one of the major players operating in the Cardiac Marker Analyzer market, holding a share of 21.59% in 2022.

Abbott Laboratories

Abbott Laboratories (Abbott) discovers, develops, manufactures and sells a diversified range of healthcare products including branded generic pharmaceuticals, diagnostic systems and tests, and pediatric and adult nutritional products.

Siemens Healthcare

Siemens Healthineers is a healthcare technology company that provides diagnostic and therapeutic products and services.

Segmentation Overview:

Among different product types, Immuno-Fluorescence Analyzers (IFA) segment is anticipated to contribute the largest market share in 2027.

Application Overview:

By application, the Hospitals segment occupied the biggest share from 2017 to 2022.

Key Companies in the global Cardiac Marker Analyzer market covered in Chapter 3:

Beckman-Coulter
BioMerieux
Trinity Biotech
Radiometer Medical
Boditech
LSI Medience Corporation
Roche Diagnostics
Getein Biotechnology
LifeSign
Abbott Laboratories
Siemens Healthcare
CardioGenics

In Chapter 4 and Chapter 14.2, on the basis of types, the Cardiac Marker Analyzer market from 2018 to 2029 is primarily split into:

Immuno-Fluorescence Analyzers (IFA)
Magnetic Immuno-Chromatographic Assay (MICA) Analyzers
Chemiluminiscenece Immunoassay (CLIA) Analyzers
Radioimmunoassay (RIA) Analyzers
Enzyme Immunoassay (EIA) Analyzers

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Cardiac Marker Analyzer market from 2018 to 2029 covers:

Hospitals
Diagnostic Centers
Academic and Research institutes

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)